GGrantIndex
Sort

130,381 grants matching hiv

Sex Hormone Regulation of Innate Immunity in Women &Men

$1,599,050
Dartmouth College · P01 · FY2005 · AI

California NeuroAIDS Tissue Network (CNTN)

$1,598,999
Igor Grant · University Of California, San Diego · U01 · FY2012 · MH

ADULTS AIDS CLINICAL TRIALS UNIT UPR ADULT ACTU

$1,598,938
University Of Puerto Rico Med Sciences · U01 · FY2003 · AI

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs

$1,598,807
Thomas Quinn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

HIV PREVENTION PROJECTS

$1,598,713
Mary Ann Ann Cooney · Nh State Dept/Hlth Statistics/Data Mgmt · U62 · FY2007 · PS

CENTER FOR AIDS RESEARCH(CFAR)

$1,598,632
Michael Marcel Lederman · Case Western Reserve University · P30 · FY2007 · AI

Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs

$1,598,512
Gavin Walton · Careworks · U2G · FY2016 · GH

PLCO Trial Etiologic and Early Marker Study

$1,598,190
Steven Moore · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA

Pathogenesis and Treatment of HIV Infection

$1,597,374
H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Units for HIV/AIDS Clinical Trials Networks

$1,597,142
Michael C Keefer · University Of Rochester · UM1 · FY2013 · AI

QUANTITATIVE VIRAL OUTGROWTH ASSAY (QVOA) SERVICE RESOURCE

$1,597,076
Michael Murray · Southern Research Institute · N01 · FY2015 · AI

Computational Biology and Biostatistics Core

$1,596,937
Bette T. Korb · Duke University · U19 · FY2007 · AI

A Comprehensive Community-based Strategy to Optimize the HIV Prevention and Treatment Continuum for Youth At HIV Risk, Acutely Infected and with Established HIV Infection

$1,596,769
Dallas Travis Swendeman · University Of California Los Angeles · U19 · FY2022 · HD

Immunologic control of HIV-1 through combination bNAbs and biologics.

$1,596,752
Marina Caskey · Rockefeller University · U01 · FY2023 · AI

T Cell Immune Responses To HIV And Other Pathogens

$1,596,278
Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI

Lifespan/Tufts/Brown Center for AIDS Research (CFAR)

$1,596,224
Charles Cj Carpenter · Miriam Hospital · P30 · FY2010 · AI

A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies

$1,596,167
David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2020 · HL

Active Immune Therapy and HAART for HIV-1 Infection

$1,596,146
University Of Pennsylvania · U19 · FY2004 · AI

Combination immunotherapy with gene modified CD4 and CD8 T cells and stem cells

$1,596,110
Carl H. June · University Of Pennsylvania · U19 · FY2013 · AI

A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs

$1,595,847
Lisa R Metsch · Columbia University Health Sciences · R01 · FY2016 · DA

Nanoparticle-based development for HIV-1 biomolecule delivery

$1,595,794
Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2021 · AI

Core--Vector

$1,595,516
Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2007 · AI

The Role of Host Factors in HIV Immunopathogenesis

$1,595,345
Anthony S. Fauci · Niaid Extramural Activities · Z01 · FY2007 · AI

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$1,595,335
Seema Dixit · Rhode Island State Dept Of Health · U62 · FY2014 · PS

COLORADO ADULT AIDS CLINICAL TRIALS UNIT

$1,595,271
Thomas B. Campbell · University Of Colorado Denver · U01 · FY2006 · AI